BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16024181)

  • 1. Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients.
    Bachtiary B; Dewitt A; Pintilie M; Jezioranski J; Ahonen S; Levin W; Manchul L; Yeung I; Milosevic M; Fyles A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1077-82. PubMed ID: 16024181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
    Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.
    Ziemlewski A; Zienkiewicz J; Serkies K; Badzio A
    Strahlenther Onkol; 2007 Sep; 183(9):512-6. PubMed ID: 17762926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: a comparison of outcomes.
    Pohar S; Haq R; Liu L; Koniarczyk M; Hahn S; Damron T; Aronowitz JN
    Brachytherapy; 2007; 6(1):53-7. PubMed ID: 17284387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
    Pötter R; Dimopoulos J; Bachtiary B; Sissolak G; Klos B; Rheinthaller A; Kirisits C; Knocke-Abulesz TH
    Radiother Oncol; 2006 Apr; 79(1):80-6. PubMed ID: 16516316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
    Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
    J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.